Compared with nodal status, a clinical characteristic closely correlated with tumor volume,30, 31, 32 Ki67 labeling index, which is a biologic characteristic, more reliably predicted response to initial exemestane monotherapy. This evidence concerns the gene MKI67 and neoplasm.